← Back to all trials
Completed
NCT06510166
The Effect of Distraction Methods Used During Inhalation Therapy on Children's Fear and Anxiety: : Randomize Controlled Study
Conditions: Child, Inhalation Therapy; Complications, Fear, Distraction Methods, Anxiety
Sex: All
Ages: 3 Years – 6 Years
Healthy volunteers: No
Phase: NA
Enrollment: 120
Sponsor: Ondokuz Mayıs University
Location: Ondokuz Mayıs University Samsun Atakum
Summary
It was aimed to examine the effects of distraction methods used during inhalation therapy on children's fear and anxiety.
Hypothesis:
Hypothesis 0 (H0): There is no difference between the fear and anxiety levels of children who received normal nebulizer + mask + distraction techniques and toy type nebulizer + toy mask during inhaler treatment and the children in the control group.
Hypothesis 1 (H1): The fear and anxiety levels of children who received normal nebulizer + mask + distraction techniques during inhaler treatment are lower than the children in the control group.
Hypothesis 2 (H2): The fear and anxiety levels of children who were applied a toy type nebulizer + toy mask during inhaler treatment are lower than the children in the control group.
Hypothesis 3 (H3): The fear and anxiety levels of children who were treated with a toy type nebulizer + toy mask during inhaler treatment were lower than those of children who were treated with a normal nebulizer + mask + distraction techniques.
Eligibility Criteria
Inclusion Criteria:
* Parent and child volunteer to participate in the study,
* The child is between 3-6 years old,
* Presentation due to upper and lower respiratory tract infection,
* Inhaler treatment will be applied with a nebulizer,
* No request for any other intravenous, intramuscular or invasive treatment,
* The child does not have any genetic, congenital, chronic or metabolic disease,
Exclusion Criteria:
* Parent and child are not willing to participate in the study,
* The child is not between 3-6 years old,
* Presentation for a reason other than upper and lower respiratory tract infection,
* No inhaler treatment with a nebulizer,
* Request for any other intravenous, intramuscular or invasive treatment,
* The child has any genetic, congenital, chronic or metabolic disease
Source: ClinicalTrials.gov (NCT06510166). StuddyBuddy aggregates publicly available trial information.